We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Earlier this month, the U.S. Supreme Court issued a decision in Microsoft Corp. v. i4i L.P., 589 F.3d 1246 (Fed. Cir. 2009), upholding a Federal Circuit Court of Appeals decision affirming an award of close to $300 million in damages to software developer i4i for willful patent infringement
In Mayo v. Prometheus, the U.S. Supreme Court held that claims directed to a diagnostic method were unpatentable, not simply because the subject matter of the claims was not novel or obvious, but rather because the subject matter covered by the claims was the mere application of the laws of nature - the discovery of facts of nature - and therefore not patentable on a more fundamental basis under Section 101 of the Patent Act
The U.S. Court of Appeals for the Federal Circuit vacated and remanded a Delaware court's finding that Medtronic Inc. did not infringe Boston Scientific patents relating to cardiac rhythm therapy (CRT) devices known as implantable cardioverter defribrillators (ICDs
PageMelding filed a patent infringement action against ESPN asserting a patent that enables internet service and content providers to form mutually beneficial collaborations where website content is customized in accordance with those collaborations
After passing Congress with bipartisan support, the Leahy-Smith America Invents Act, also known as the Patent Reform Act, was signed by President Barack Obama on September 16, 2011
